The dose-finding phase 2 trial randomised 706 adults with obesity, or overweight plus at least one weight-related comorbidity, to once-weekly cagrilintide at 0.3, 0.6, 1.2, 2.4 or 4.5 mg, weekly placebo, or daily liraglutide 3.0 mg as an active comparator, all alongside lifestyle intervention
Our personalized approach to medical weight loss integrates this advanced medication with tailored treatment plans to help you achieve significant and sustainable results
HOUSTON, Texas -- A woman will spend eight years behind bars for a botched cosmetic procedure that killed another woman in 2018, according to records
It has been shown to lower total cholesterol, triglycerides, LDL cholesterol, and apolipoproteins such as Apo-B, while sometimes increasing beneficial components like Apo-A1